Royal Bank of Canada (RY)

RBC Capital noted that ResMed now has “a number of competitive threats on the horizon."

The two companies dominate the home improvement retail space, a category where consumer spending typically rises during periods of strong economic confidence.

Truist Securities analyst revised price forecast on RBC Bearings to $405, keeping Buy rating. Q4 EPS beat, sales missed. Q1 sales expected to be $424M-$434M.

Bearings manufacturer RBC Bearings (NYSE:RBC) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 5.8% year on year to $437.7 million. Next quarter’s revenue guidance of $429 million underwhelmed, coming in 0.9% below analysts’ estimates. Its non-GAAP profit of $2.83 per share was 4.7% above analysts’ consensus estimates.

Bearings manufacturer RBC Bearings (NYSE:RBC) will be announcing earnings results tomorrow before market open. Here’s what to expect.

The announcement follows a slew of price cuts from analysts after the company’s second-quarter outlook disappointed Wall Street.

At least two research firms said the stock may have bottomed following the “latest in a string of setbacks.”

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.

Trade Desk stock rose after the digital advertising firm rebounded with a better-than-expected Q1 after lowering expectations in early 2025. 

Analysts warn that while Palantir's execution is impressive, concerns remain that its stock trades at a valuation difficult to justify without further acceleration.

The company reported a strong start for its newest drug, Crenessity, which treats a hormonal disorder involving the adrenal glands.

The company paused a study of a cystic fibrosis treatment, right on the heels of a scrapped type 1 diabetes program.

B of A Securities analyst maintains Buy rating on Chevron Corp. despite mixed Q1 earnings. Reiterates attractive investment due to strong cash flow and financial position. RBC Capital Markets also rates CVX Outperform with $175 price target.

Wall Street expects the oil and gas producer to post adjusted earnings of $4.20 per share on revenue of $3.75 billion.

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

The RSA conference this week didn't deliver much breaking news on cybersecurity stocks but Wall Street analysts came away upbeat on industry trends.

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.